Insights & Updates in Treatment and Prevention of Recurrent CDI
This is a series of educational CME commentaries covering updates and insights on the treatment and prevention of recurrent clostridium difficile infection (CDI) and its impact on community-based and hospitalized patients. A patient who experienced several episodes of recurrent C. difficile will provide her perspectives.
Digital Q&A Interview with Paul Feuerstadt, MD
Expert Perspectives on New Guidelines and Approaches to Reduce Risk in Patients with C. difficile
Clinical CommentaryIn this CME video-based interview, Dr. David Binion will review the 2017 IDSA/SHEA guidelines for the treatment of initial and recurrent episodes of C. difficile. Dr. Binion will discuss data that informed the guidelines and the clinical implications of the guidelines. A patient will also provide her perspectives on experiencing several episodes of recurrent C. difficile. This is the first in a series of three educational activities on CDI to be released in 2018.
Faculty: David Binion, MD
Release Date:
Expiration Date: August 29, 2019
CME/CE is no longer available for this activity
Breaking the Cycle of C. difficile: Focus on Community-acquired Infections and Recurrence
Clinical CommentaryIn this CME video-based interview, Dr. Sahil Khanna will review the changing epidemiology of community-acquired C. difficile and advances in its diagnosis and prevention. Dr. Khanna will also discuss approaches to the treatment of initial and recurrent episodes of C. difficile. A patient who experienced several episodes of recurrent C. difficile will provide her perspectives. This is the second in a series of three educational activities on CDI to be released in 2018.
Faculty: Sahil Khanna, MBBS, MS
Release Date:
Expiration Date: September 28, 2019
CME/CE is no longer available for this activity
C. difficile Infection and Recurrence: Targeting the Drivers of Pathogenesis
CME TouchpointClostridium difficile infection (CDI) is associated with significant morbidity and mortality. Recurrence is common after an initial episode. Although a number of therapies with varying mechanisms of action, are available to treat CDI and prevent recurrence, the management of CDI is complex and challenging. To address these challenges, IDSA/SHEA recently updated their guidelines to include new data and more aggressive approaches to treatment. Clinicians require up-to-date knowledge of evidence-based treatment of initial and recurrent CDI to improve clinical outcomes. In this CME eNewsletter, Dr. Paul Feuerstadt will discuss the body’s defenses against C. difficile infection, including the immune response and changes in the gut microbiome. This is the final activity in a series of three educational activities on CDI released in 2018.
Faculty: Paul Feuerstadt, MD
Release Date:
Expiration Date: November 27, 2019
CME/CE is no longer available for this activity
